Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 236

1.

Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report.

Trecarichi EM, Quirino A, Scaglione V, Longhini F, Garofalo E, Bruni A, Biamonte E, Lionello R, Serapide F, Mazzitelli M, Marascio N, Matera G, Liberto MC, Navalesi P, Torti C; IMAGES Group .

J Antimicrob Chemother. 2019 Aug 1. pii: dkz318. doi: 10.1093/jac/dkz318. [Epub ahead of print] No abstract available.

PMID:
31369095
2.

[Good practices for the surveillance and control of antimicrobial resistance].

Moro ML, Ciofi Degli Atti M, D'Amore C, Diegoli G, Forni S, Gagliotti C, Gemmi F, Iannazzo S, Miraglia V, Pan A, Pantosti A, Pitatlis S, Puro V, Ricchizzi E, Sarnelli B, Torti C, Zotti C.

Epidemiol Prev. 2019 Mar-Jun;43(2-3):185-193. doi: 10.19191/EP19.2-3.P185.058. Italian.

3.

Use of colistin in adult patients: a cross-sectional study.

Giacobbe DR, Saffioti C, Losito AR, Rinaldi M, Aurilio C, Bolla C, Boni S, Borgia G, Carannante N, Cassola G, Ceccarelli G, Corcione S, Gasperina DD, De Rosa FG, Dentone C, Di Bella S, Di Lauria N, Feasi M, Fiore M, Fossati S, Franceschini E, Gori A, Granata G, Grignolo S, Grossi PA, Guadagnino G, Lagi F, Maraolo AE, Marinò V, Mazzitelli M, Mularoni A, Oliva A, Pace MC, Parisini A, Patti F, Petrosillo N, Pota V, Raffaelli F, Rossi M, Santoro A, Tascini C, Torti C, Trecarichi EM, Venditti M, Viale P, Signori A, Bassetti M, Del Bono V, Giannella M, Mikulska M, Tumbarello M, Viscoli C; SITA GIOVANI, (young investigators group of the Società Italiana Terapia Antinfettiva), the COLI-CROSS study group.

J Glob Antimicrob Resist. 2019 Jun 14. pii: S2213-7165(19)30153-5. doi: 10.1016/j.jgar.2019.06.009. [Epub ahead of print]

PMID:
31207379
4.

Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4.

Marascio N, Mazzitelli M, Pavia G, Giancotti A, Barreca GS, Costa C, Pisani V, Greco G, Serapide F, Trecarichi EM, Casalinuovo F, Liberto MC, Matera G, Torti C.

Cells. 2019 May 5;8(5). pii: E416. doi: 10.3390/cells8050416.

5.

Discussion on critical points for a tailored therapy to cure hepatitis C virus infection.

Marascio N, Quirino A, Barreca GS, Galati L, Costa C, Pisani V, Mazzitelli M, Matera G, Liberto MC, Focà A, Torti C.

Clin Mol Hepatol. 2019 Mar;25(1):30-36. doi: 10.3350/cmh.2018.0061. Epub 2019 Jan 23. Review.

6.

Identification of human papillomavirus type 16 variants circulating in the Calabria region by sequencing and phylogenetic analysis of HPV16 from cervical smears.

Galati L, Equestre M, Bruni R, Accardi L, Torti C, Fiorillo MT, Surace G, Barreca GS, Liberto MC, Focà A, Ciccaglione AR, Di Bonito P.

Infect Genet Evol. 2019 Mar;68:185-193. doi: 10.1016/j.meegid.2018.12.024. Epub 2018 Dec 20.

PMID:
30578936
7.

Prevalence of parasitic infections in migrants: do official symptom-driven guidelines apply to the current situation?

Mazzitelli M, Torti C, Greco G, Strazzulla A, Costa C, Pisani V, Sorace C, Giancotti A, Lamberti A, Barreca GS, Quirino A, Liberto MC, Focà A, Matera G.

Infez Med. 2018 Dec 1;26(4):347-355.

8.

Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients.

Mazzitelli M, Torti C, Sabatino J, D'Ascoli GL, Costa C, Pisani V, Raffetti E, De Rosa S, Strazzulla A, Focà A, Liberto MC, Indolfi C; CARDIAC study group.

BMC Infect Dis. 2018 Oct 16;18(1):518. doi: 10.1186/s12879-018-3426-9.

9.

The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy.

Schultze A, Torti C, Cozzi-Lepri A, Vandamme AM, Zazzi M, Sambatakou H, De Luca A, Geretti AM, Sonnerborg A, Ruiz L, Monno L, Di Giambenedetto S, Gori A, Lapadula G; European Transmitted Drug Resistance collaboration (EU-TDR).

AIDS. 2019 Feb 1;33(2):315-326. doi: 10.1097/QAD.0000000000002046.

PMID:
30325769
10.

Utility of Molecular Identification and Quantitation of Bartonella Species with Species-Specific Real-Time PCR for Monitoring Treatment Response: A Case Series.

Mazzitelli M, Lamberti AG, Quirino A, Marascio N, Barreca GS, Costa C, Pisani V, Strazzulla A, Greco G, Liberto MC, Focà A, Torti C.

Open Microbiol J. 2018 May 31;12:148-153. doi: 10.2174/1874285801812010148. eCollection 2018.

11.

Depression of lymphocyte activity during cutaneous leishmaniasis: a case report.

Matera G, Torti C, Mazzitelli M, Greco G, Rania A, Peronace C, Settembre P, Galati L, Giancotti A, Lamberti AG, Barreca GS, Rossi M, Quirino A, Liberto MC, Focà A.

Diagn Microbiol Infect Dis. 2018 Nov;92(3):230-234. doi: 10.1016/j.diagmicrobio.2018.05.025. Epub 2018 Jun 2.

PMID:
29950279
12.

Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016.

Rossetti B, Di Giambenedetto S, Torti C, Postorino MC, Punzi G, Saladini F, Gennari W, Borghi V, Monno L, Pignataro AR, Polilli E, Colafigli M, Poggi A, Tini S, Zazzi M, De Luca A; Antiviral Response Cohort Analysis (ARCA) Collaborative Group.

HIV Med. 2018 Oct;19(9):619-628. doi: 10.1111/hiv.12640. Epub 2018 Jun 22.

PMID:
29932313
13.

Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals.

Strazzulla A, Coppolino G, Barreca GS, Gentile I, Rivoli L, Postorino MC, Mazzitelli M, Greco G, Costa C, Pisani V, Marascio N, Simeoni M, Focà A, Fuiano G, Foti D, Gulletta E, Torti C.

Clin Mol Hepatol. 2018 Jun;24(2):151-162. doi: 10.3350/cmh.2017.0059. Epub 2018 Apr 24.

14.

Real-life 3D therapy failure: Analysis of NS5A 93H RAS plus 108 K polymorphism in complex with ombitasvir by molecular modeling.

Marascio N, Pavia G, Romeo I, Talarico C, Di Salvo S, Reale M, Marano V, Barreca GS, Fabiani F, Perrotti N, De Siena M, Giancotti F, Gravina T, Alcaro S, Artese A, Torti C, Liberto MC, Focà A.

J Med Virol. 2018 Jul;90(7):1257-1263. doi: 10.1002/jmv.25073. Epub 2018 Mar 31.

PMID:
29575060
15.

Increase of Vascular Endothelial Growth Factor and Decrease of MCP-1 and Some Updated Epidemiology Aspects of Cystic Echinococcosis Human Cases in Calabria Region.

Matera G, Loria MT, Peronace C, Catanzariti T, Settembre P, Giancotti A, Lamberti AG, Barreca GS, Galati L, Dodaro G, Mazzitelli M, Strazzulla A, Torti C, Quirino A, Liberto MC, Focà A.

Mediators Inflamm. 2018 Jan 14;2018:4283672. doi: 10.1155/2018/4283672. eCollection 2018.

16.

Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment.

Barone S, Scannapieco S, Torti C, Filippelli E, Pisani V, Granata A, Console D, Demonte G, Tallarico T, Polidoro S, Quattrone A, Valentino P.

Mult Scler Relat Disord. 2018 Feb;20:6-8. doi: 10.1016/j.msard.2017.12.009. Epub 2017 Dec 18.

PMID:
29272733
17.

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study.

Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, Böni J, Brun-Vezinet F, Soriano V, Boufassa F, Brockmeyer N, Calmy A, Dabis F, Jarrin I, Dorrucci M, Duque V, Fätkenheuer G, Zangerle R, Ferrer E, Porter K, Judd A, Sipsas NV, Lambotte O, Shepherd L, Leport C, Morrison C, Mussini C, Obel N, Ruelle J, Schwarze-Zander C, Sonnerborg A, Teira R, Torti C, Valadas E, Colin C, Friis-Møller N, Costagliola D, Thiebaut R, Chene G, Matheron S; COHERE in EuroCoord and ACHIeV2e Study Group.

J Antimicrob Chemother. 2017 Oct 1;72(10):2869-2878. doi: 10.1093/jac/dkx210.

18.

Nodular morphea in a patient with Steinert disease.

Campione E, Ventura A, Garofalo V, Torti C, Massa R, Terracciano C, Orlandi A, Bianchi L.

G Ital Dermatol Venereol. 2019 Apr;154(2):209-210. doi: 10.23736/S0392-0488.17.05624-3. Epub 2017 Sep 8. No abstract available.

PMID:
28895373
19.

Knowledge of Human Cytomegalovirus Infection and Prevention in Pregnant Women: A Baseline, Operational Survey.

Mazzitelli M, Micieli M, Votino C, Visconti F, Quaresima P, Strazzulla A, Torti C, Zullo F.

Infect Dis Obstet Gynecol. 2017;2017:5495927. doi: 10.1155/2017/5495927. Epub 2017 Jul 31.

20.

Natural NS5A inhibitor resistance associated substitutions in hepatitis C virus genotype 1 infected patients from Italy.

Caudai C, Materazzi A, Saladini F, Di Giambenedetto S, Torti C, Ricciardi B, Rossetti B, Almi P, De Luca A, Zazzi M.

Clin Microbiol Infect. 2018 Mar;24(3):308.e5-308.e8. doi: 10.1016/j.cmi.2017.08.003. Epub 2017 Aug 12.

21.

Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals.

Ferro Y, Carè I, Mazza E, Provenzano F, Colica C, Torti C, Romeo S, Pujia A, Montalcini T.

Clin Mol Hepatol. 2017 Sep;23(3):249-259. doi: 10.3350/cmh.2017.0019. Epub 2017 Jul 28.

22.

Patterns of multi-drug resistant bacteria at first culture from patients admitted to a third level University hospital in Calabria from 2011 to 2014: implications for empirical therapy and infection control.

Reale M, Strazzulla A, Quirino A, Rizzo C, Marano V, Postorino MC, Mazzitelli M, Greco G, Pisani V, Costa C, Cesana BM, Liberto MC, Torti C, Focà A.

Infez Med. 2017 Jun 1;25(2):98-107.

23.

Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort.

Postorino MC, Prosperi M, Focà E, Quiros-Roldan E, Di Filippo E, Maggiolo F, Borghetti A, Ladisa N, Di Pietro M, Gori A, Sighinolfi L, Pan A, Mazzini N, Torti C.

BMC Infect Dis. 2017 Mar 15;17(1):212. doi: 10.1186/s12879-017-2322-z.

24.

Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy.

Cuypers L, Vrancken B, Fabeni L, Marascio N, Cento V, Di Maio VC, Aragri M, Pineda-Peña AC, Schrooten Y, Van Laethem K, Balog D, Focà A, Torti C, Nevens F, Perno CF, Vandamme AM, Ceccherini-Silberstein F.

BMC Evol Biol. 2017 Mar 7;17(1):70. doi: 10.1186/s12862-017-0913-3.

25.

The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real?

Strazzulla A, Iemmolo RMR, Carbone E, Postorino MC, Mazzitelli M, De Santis M, Di Benedetto F, Cristiani CM, Costa C, Pisani V, Torti C.

Hepat Mon. 2016 Oct 30;16(11):e41933. doi: 10.5812/hepatmon.41933. eCollection 2016 Nov.

26.

Knowledge of HIV infection and transmission: a knowledge, attitudes, beliefs and practices (KABP) survey among a sample of students at the "Magna Graecia", University of Catanzaro.

Mazzitelli M, Caridà G, Scigliano C, Vallone MC, Pirrò F, Lombardo MR, Clemente G, Bernaudo F, Postorino MC, Strazzulla A, Maselli R, Torti C.

Ann Ist Super Sanita. 2016 Oct-Dec;52(4):530-535. doi: 10.4415/ANN_16_04_12.

27.

A case report of Schistosoma haematobium infection in a pregnant migrant raises concerns about lack of screening policies.

Mazzitelli M, Matera G, Votino C, Visconti F, Strazzulla A, Loria MT, Peronace C, Settembre P, Giancotti A, Liberto MC, Focà A, Zullo F, Torti C.

J Travel Med. 2016 Oct 30;24(1). pii: taw076. Print 2016 Jul.

PMID:
27799503
28.

Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment.

Lapadula G, Bernasconi DP, Casari S, Maggiolo F, Cauda R, Di Pietro M, Ladisa N, Sighinolfi L, Dal Zoppo S, Sabbatini F, Soria A, Pezzoli C, Mondi A, Costarelli S, Valsecchi MG, Torti C, Gori A; Italian MASTER cohort.

PLoS One. 2016 Sep 15;11(9):e0162320. doi: 10.1371/journal.pone.0162320. eCollection 2016.

29.

Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.

Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, Sabin C, van Sighem A, Ledergerber B, Torti C, Mocroft A, Podzamczer D, Dorrucci M, De Wit S, Obel N, Dabis F, Cozzi-Lepri A, García F, Brockmeyer NH, Warszawski J, Gonzalez-Tome MI, Mussini C, Touloumi G, Zangerle R, Ghosn J, Castagna A, Fätkenheuer G, Stephan C, Meyer L, Campbell MA, Chene G, Phillips A; Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

HIV Med. 2017 Mar;18(3):171-180. doi: 10.1111/hiv.12411. Epub 2016 Sep 14.

30.

Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.

Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d'Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, De Wit S, Fätkenheuer G, Zangerle R, Ghosn J, Pérez-Hoyos S, Campbell M, Prins M, Chêne G, Meyer L, Dorrucci M, Torti C, Thiébaut R; Standard Reference Distribution of CD4 Response to HAART Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

HIV Med. 2017 Jan;18(1):33-44. doi: 10.1111/hiv.12389. Epub 2016 Sep 14.

31.

Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve Patients.

Marascio N, Pavia G, Strazzulla A, Dierckx T, Cuypers L, Vrancken B, Barreca GS, Mirante T, Malanga D, Oliveira DM, Vandamme AM, Torti C, Liberto MC, Focà A; The SINERGIE-UMG Study Group.

Int J Mol Sci. 2016 Aug 27;17(9). pii: E1416. doi: 10.3390/ijms17091416.

32.

Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy.

Mengoli C, Andreis S, Scaggiante R, Cruciani M, Bosco O, Ferretto R, Leoni D, Maffongelli G, Basso M, Torti C, Sarmati L, Andreoni M, Palù G, Parisi SG.

J Antimicrob Chemother. 2017 Jan;72(1):220-226. Epub 2016 Sep 7.

PMID:
27605599
33.

Is it time to move from standard to targeted surgical prophylaxis?

Quirino A, Torti C, Cortese G, Morelli P, Reale MC, Mastroroberto P, Matera G, Liberto MC, Focà A.

J Hosp Infect. 2016 Nov;94(3):255-256. doi: 10.1016/j.jhin.2016.07.020. Epub 2016 Aug 17. No abstract available.

PMID:
27597266
34.

Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function.

Postorino MC, Quiros-Roldan E, Maggiolo F, Di Giambenedetto S, Ladisa N, Lapadula G, Lorenzotti S, Sighinolfi L, Castelnuovo F, Di Pietro M, Gotti D, Mazzini N, Torti C; MASTER Study Group.

Open AIDS J. 2016 Jul 15;10:136-43. doi: 10.2174/1874613601610010136. eCollection 2016.

35.

The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort.

Raffetti E, Postorino MC, Castelli F, Casari S, Castelnuovo F, Maggiolo F, Di Filippo E, D'Avino A, Gori A, Ladisa N, Di Pietro M, Sighinolfi L, Zacchi F, Torti C.

BMC Public Health. 2016 Aug 25;16(1):878. doi: 10.1186/s12889-016-3477-z.

36.

Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study.

Focà E, Fabbiani M, Prosperi M, Quiros Roldan E, Castelli F, Maggiolo F, Di Filippo E, Di Giambenedetto S, Gagliardini R, Saracino A, Di Pietro M, Gori A, Sighinolfi L, Pan A, Postorino MC, Torti C; Italian MASTER Cohort.

Medicine (Baltimore). 2016 Jul;95(29):e4091. doi: 10.1097/MD.0000000000004091.

37.

Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?

Strazzulla A, Coppolino G, Di Fatta C, Giancotti F, D'Onofrio G, Postorino MC, Mazzitelli M, Mammone SV, Gentile I, Rivoli L, Palella E, Gravina T, Costa C, Pisani V, De Maria V, Barreca GS, Marascio N, Focà A, Fuiano G, Gulletta E, Torti C.

World J Hepatol. 2016 Jul 8;8(19):815-24. doi: 10.4254/wjh.v8.i19.815.

38.

Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.

Borges ÁH, Lundh A, Tendal B, Bartlett JA, Clumeck N, Costagliola D, Daar ES, Echeverría P, Gisslén M, Huedo-Medina TB, Hughes MD, Huppler Hullsiek K, Khabo P, Komati S, Kumar P, Lockman S, MacArthur RD, Maggiolo F, Matteelli A, Miro JM, Oka S, Petoumenos K, Puls RL, Riddler SA, Sax PE, Sierra-Madero J, Torti C, Lundgren JD.

Clin Infect Dis. 2016 Jul 15;63(2):268-80. doi: 10.1093/cid/ciw236. Epub 2016 Apr 18. Review.

39.

Is hand-grip another culprit for the risk of fractures in HIV-positive patients?

Postorino MC, Torti C, Carè I, Pisani V, Strazzulla A, Vaccaro V, Costa C, Provenzano F, Mazzitelli M, Pujia A, Montalcini T.

New Microbiol. 2016 Jan;39(1):61-4.

40.

Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.

Fontana RJ, Brown RS Jr, Moreno-Zamora A, Prieto M, Joshi S, Londoño MC, Herzer K, Chacko KR, Stauber RE, Knop V, Jafri SM, Castells L, Ferenci P, Torti C, Durand CM, Loiacono L, Lionetti R, Bahirwani R, Weiland O, Mubarak A, ElSharkawy AM, Stadler B, Montalbano M, Berg C, Pellicelli AM, Stenmark S, Vekeman F, Ionescu-Ittu R, Emond B, Reddy KR.

Liver Transpl. 2016 Apr;22(4):446-58. doi: 10.1002/lt.24416.

41.

Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.

De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D; CHAIN and COHERE in EuroCoord.

J Antimicrob Chemother. 2016 May;71(5):1352-60. doi: 10.1093/jac/dkv465. Epub 2016 Jan 28.

42.

Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men.

Scaggiante R, Andreis S, Basso M, Franchin E, Franzetti M, Del Vecchio C, Torti C, Mengoli C, Cruciani M, Sarmati L, Palù G, Parisi SG.

J Med Virol. 2016 Jul;88(7):1211-21. doi: 10.1002/jmv.24441. Epub 2015 Dec 15.

PMID:
26636290
43.

Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.

Late presenters working group in COHERE in EuroCoord, Mocroft A, Lundgren J, Antinori A, Monforte Ad, Brännström J, Bonnet F, Brockmeyer N, Casabona J, Castagna A, Costagliola D, De Wit S, Fätkenheuer G, Furrer H, Jadand C, Johnson A, Lazanas M, Leport C, Moreno S, Mussini C, Obel N, Post F, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Loano I, Torti C, Warszawski J, Wittkop L, Zangerle R, Chene G, Raben D, Kirk O.

Euro Surveill. 2015;20(47). doi: 10.2807/1560-7917.ES.2015.20.47.30070.

44.

Demographical, Viro-Immunological, Clinical and Therapeutical Characteristics of HIV-Infected Patients in an "Epidemiologically Unexplored" Region of Italy (Calabria Region): the CalabrHIV Cohort.

Postorino MC, Luciani F, Mangano C, Carpentieri MS, Scerbo P, Priamo A, Berardelli G, Marino R, Vallone A, Serrao N, Pisani V, Costa C, Terremoto A, Foti G, Cosco L, Calderazzo M, Corigliano D, Scordo P, Strazzulla A, Torti C; CalabrHIV Study Group.

Mediterr J Hematol Infect Dis. 2015 Oct 8;7(1):e2015054. doi: 10.4084/MJHID.2015.054. eCollection 2015.

45.

Virological Mechanisms in the Coinfection between HIV and HCV.

Liberto MC, Zicca E, Pavia G, Quirino A, Marascio N, Torti C, Focà A.

Mediators Inflamm. 2015;2015:320532. doi: 10.1155/2015/320532. Epub 2015 Oct 1. Review.

46.

Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort).

Torti C, Raffetti E, Donato F, Castelli F, Maggiolo F, Angarano G, Mazzotta F, Gori A, Sighinolfi L, Pan A, Cauda R, Scalzini A, Quiros-Roldan E, Nasta P, Gregis G, Benatti S, Digiambenedetto S, Ladisa N, Giralda M, Saracino A, Castelnuovo F, Di Pietro M, Lo Caputo S, Lapadula G, Costarelli S, Lorenzotti S, Mazzini N, Paraninfo G, Casari S, Focà E, Pezzoli C, Fabbiani M, Monno L, Pierotti P, Ble C, Leone S, Postorino MC, Fornabaio C, Zacchi F, Zoncada A, Carosi G.

Int J Epidemiol. 2017 Apr 1;46(2):e12. doi: 10.1093/ije/dyv192. No abstract available.

PMID:
26445966
47.

Nasopharyngeal carcinoma: review of the literature with a focus on therapeutical implications.

Strazzulla A, Barreca GS, Giancotti A, Pisani V, Costa C, Zicca E, La Boria A, Roveda L, Liberto MC, Tucci L, Donato G, Focà A, Torti C.

Infez Med. 2015 Sep;23(3):224-9. Review.

48.

Professional Acquisition of M. bovis in Calabria Region (Southern Italy): A Challenging Case of Osteomyelitis in a Migrant Patient from Bulgaria.

Quirino A, Torti C, Strazzulla A, Nisticò S, Galati L, Barreca GS, Lamberti AG, Berardelli G, Pacciarini M, Gasparini G, Pisani V, Gambardella A, Liberto MC, Focà A.

Case Rep Infect Dis. 2015;2015:794715. doi: 10.1155/2015/794715. Epub 2015 Jul 14.

49.

Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors.

De Luca A, Di Giambenedetto S, Lo Presti A, Sierra S, Prosperi M, Cella E, Giovanetti M, Torti C, Caudai C, Vicenti I, Saladini F, Almi P, Grima P, Blanc P, Fabbiani M, Rossetti B, Gagliardini R, Kaiser R, Ciccozzi M, Zazzi M.

Open Forum Infect Dis. 2015 Mar 31;2(2):ofv043. doi: 10.1093/ofid/ofv043. eCollection 2015 Apr.

50.

The case of chronic hepatitis B treatment with tenofovir: an update for nephrologists.

Coppolino G, Simeoni M, Summaria C, Postorino MC, Rivoli L, Strazzulla A, Torti C, Fuiano G.

J Nephrol. 2015 Aug;28(4):393-402. doi: 10.1007/s40620-015-0214-0. Epub 2015 Jun 9. Review.

PMID:
26054819

Supplemental Content

Support Center